Risk tips
1. Risk of performance falling short of expectations
2. Risk of international policy changes
Major changes in the laws and regulations, industrial policies or political and economic environment of the countries and regions where the overseas business is located, or the overseas business conditions are affected due to unpredictable factors such as international tension, war, trade sanctions or other force majeure, which may have a potential adverse impact on the normal and sustainable development of the overseas business.
3. Risk of declining demand in pharmaceutical R & D market
Outsourcing services depend on the expenditure and demand of customers in drugs, cell and gene therapy, as well as the discovery, analysis, testing, development, production and other outsourcing services of medical devices. In the past, benefiting from the continuous growth of the global pharmaceutical market, the increase of customers' R & D budget and the increase of customers' outsourcing proportion, customers' demand for outsourcing services continued to rise. If the development trend of the industry slows down in the future, or the outsourcing proportion decreases, it may have an adverse impact on the business.
4. Risks of changes in industrial regulatory policies
The pharmaceutical R & D service industry is a highly regulated industry. Its regulatory authorities include the drug regulatory authorities in the country or region where the company's business is carried out. These regulatory authorities generally supervise the pharmaceutical R & D service industry by formulating relevant policies and regulations. The regulatory scope can cover many aspects, such as technical indicators, standards and requirements of cross-border outsourcing services and production.
